Dados B3 › B1003 × ITSA4 · Português
Each row uses the most recent year in which BOTH companies have the figure, and says which year that is. A cell with ! carries a caveat — hover to read it. We do not name a winner: that would be a recommendation, and this site does not give any.
| indicator | B1003 | ITSA4 | year |
|---|---|---|---|
| ROE | 0.0%! | 17.3% | 2023 |
| ROIC | — | 18.4%! | no year where both have it |
| ROA | -3,196.0%! | 14.7% | 2025 |
| Gross margin | — | 24.4% | no year where both have it |
| EBIT margin | — | 219.7%! | no year where both have it |
| Net margin | — | 200.6% | no year where both have it |
| Net debt/EBITDA | — | 0.25x | no year where both have it |
| Current ratio | 0.03x! | 3.18x | 2025 |
| Revenue growth (1y) | — | 0.2% | no year where both have it |
| Revenue growth (5y CAGR) | — | 7.0% | no year where both have it |
| Piotroski F-Score | 1/9! | 5/9 | 2025 |
Priced at the first session on or after the day each filing became public — never the period close.
| indicator | B1003 | ITSA4 | year |
|---|---|---|---|
| P/E | -10.44x | 9.10x | 2024 × 2025 |
| P/B | — | 1.69x | 2024 × 2025 |
| EV/EBITDA | — | 7.99x | 2024 × 2025 |
| FCF yield | — | -0.5% | 2024 × 2025 |
Numbers on this page are live. Data version 2026-09-01-supressao-declarada · page generated 2026-09-08 14:08 UTC. If this does not match /saude, you are reading a cached copy.
Home · Methodology · Transparency · Audit it